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ABSTRACT
Objective: To understand patient engagement with
decision-making for infection management in
secondary care and the consequences associated with
current practices.
Design: A qualitative investigation using in-depth
focus groups.
Participants: Fourteen members of the public who
had received antimicrobials from secondary care in
the preceding 12 months in the UK were identified
for recruitment. Ten agreed to participate. All
participants had experience of infection
management in secondary care pathways across a
variety of South-East England healthcare institutes.
Study findings were subsequently tested through
follow-up focus groups with 20 newly recruited
citizens.
Results: Participants reported feelings of
disempowerment during episodes of infection in
secondary care. Information is communicated in a
unilateral manner with individuals ‘told’ that they have
an infection and will receive an antimicrobial (often
unnamed), leading to loss of ownership, frustration,
anxiety and ultimately distancing them from engaging
with decision-making. This poor communication drives
individuals to seek information from alternative
sources, including online, which is associated with
concerns over reliability and individualisation. Failures
in communication and information provision by
clinicians in secondary care influence individuals’
future ideas about infections and their management.
This alters their future actions towards antimicrobials
and can drive prescription non-adherence and loss to
follow-up.
Conclusions: Current infection management and
antimicrobial prescribing practices in secondary care
fail to engage patients with the decision-making
process. Secondary care physicians must not view
infection management episodes as discrete events, but
as cumulative experiences which have the potential to
shape future patient behaviour and understanding of
antimicrobial use.
INTRODUCTION
Antimicrobial resistance (AMR) is a global
patient health and safety issue, with estimates
that up to 10 million deaths each year may
be attributable to AMR by the year 2050.1
Antimicrobial stewardship (AMS) pro-
grammes have been introduced at local and
international levels in an attempt to optimise
the use of antimicrobials. These interven-
tions aim to achieve the best therapeutic out-
comes of treatment, while minimising the
harmful consequences of antimicrobial
therapy, such as toxicity and development of
AMR.2–8 To date, most AMS interventions
have focused on healthcare providers with
current patient engagement interventions
around AMR and AMS (mainly via public
health interventions) difficult to assess for
efficacy.9–20
Despite a paucity of evidence to support
patient focused interventions within AMS
Strengths and limitations of this study
▪ This study adds to the paucity of evidence sur-
rounding the patient experience of infection man-
agement in secondary care pathways.
▪ Our findings provide evidence to support develop-
ment of interventions to address identified failures
of information provision and communication with
patients locally.
▪ This study was an in-depth investigation of a
small number of individuals who have been
managed for infections within secondary care
pathways over the last 12 months.
▪ Findings were tested with a separate cohort of
20 citizens for validation; this work will facilitate
the development of targeted interventions to
address the challenges identified within our
initial study.
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programmes, a growing body of literature is emerging
that describes physician’s and patient’s desire for
increased collaboration in the decision-making process
surrounding the prescription of medications within sec-
ondary care.21 However, there is currently no specific
evidence describing patients’ experiences of infection
management and antimicrobial prescribing within this
setting. Within primary care, the role of shared decision-
making (SDM), where patients and clinicians come
together, acknowledge that there is a decision to be
made (ie, between treatments and including no treat-
ment), and consider the best available evidence with the
patient’s values, preferences and context have been
demonstrated to reduce the rates of antimicrobial pre-
scribing for respiratory tract infections.22 However in sec-
ondary care, where infections are often more serious,
requiring urgent and highly protocol driven manage-
ment, the role for the patient in this process remains
unclear.
The aim of this qualitative study was to investigate
patients’ current experiences of infection related
decision-making processes across secondary care path-
ways and map how these experiences influence future
engagement with infection management and antimicro-
bial use. Through generalisation of our findings from
this in-depth investigation we hope to inform future
patient-focused interventions to address the issues identi-
fied and allow assessment of their impact on patient out-
comes and AMR within secondary care pathways.
METHOD
Participant recruitment
In September 2015, 14 members of the public who had
received antimicrobials from a secondary care pathway
in the preceding 12 months in the UK were identified
for recruitment (through Cherry Picked, London, UK; a
specialist qualitative recruitment service). This involved
identifying a sample of 500 individuals who lived in
South-East England and met recruitment criteria
(box 1) from a database of 20 000 citizens who had pre-
viously signed up to the recruitment service from
around the UK. The sample cohort of 500 were con-
tacted with an initial recruitment email to identify those
available to take part in the focus group sessions. From
there, participants were then stratified according to
recruitment criteria and 14 selected based on their fit
with the criteria and availability for the session. Two
further contacts were made with identified participants
following this to confirm their participation and provide
directions to the venue. Four individuals declined to par-
ticipate, giving no reason for this.
Participants attended focus group interviews at
Imperial College London (UK). A small sample size was
selected in order to gain an in-depth understanding of
individuals’ views, thus providing a richness to the data
available for analysis.23 Furthermore, focus groups were
selected over individual interviews as these allowed for
group exploration of new ideas, point-counterpoint dis-
cussion and resolution of views; allowing identification
and consensus on common themes within the groups.23
All individuals were consented prior to participation.
Participants completed a questionnaire collecting demo-
graphic data and previous healthcare experiences. The
validated Single Item Literacy Screener (SILS) screening
tool was included to assess the participant’s level of
health literacy,24 to allow estimation of the group’s rate
of health literacy and comparison to that of the general
population. This was felt to be important for consider-
ation, given that the findings of this study may be used
to inform future interventions in clinical practice. A
reimbursement of £65 (US$100) was provided to partici-
pants for their time.
Participant focus groups
The group was divided into two equal groups based on
age categories and gender. Two healthcare professionals
(TMR, LSPM), following a predetermined schedule (see
online supplementary data 1; developed from a critical
analysis of the literature), facilitated a 120 min focus
group. This aimed to explore the participants’ experi-
ences of engagement with decision-making surrounding
infection management and antimicrobial use in second-
ary care pathways. Two independent observers (one lay
and one healthcare professional; BH and EC-S) directly
observed the sessions and were asked to make notes of
key observations. These were used to help triangulation
of initial codes during analysis.
Data analysis
Focus groups were audio recorded and transcribed ver-
batim (using anonymous participant identifiers).
Thematic analysis of transcripts was performed using a
mixed deductive and inductive approach.25 Deductive
categories were identified based on review of the
Box 1 Selection criteria for participation in in-depth focus
group analysis of current experience of patient engagement
with infection management and antimicrobial prescribing
across secondary care
▸ Age 18 or older.
▸ Equal gender mix.
▸ Representative mix of ethnic backgrounds.
▸ Must have been treated with antibiotics in the secondary care
setting (this could include, outpatients, Emergency
Departments, Urgent Care Centres or Ambulatory units) within
the last 12 months. This should not have been level 2 or 3
care (eg, high dependency units or intensive care) only.*
▸ Preferable that they have been an inpatient in secondary care
previously (but not an exclusion criterion if the above criteria
are all satisfied).
*Individuals receiving antimicrobials in level 2 or level 3 care
facilities only were excluded, given that they are likely to have
been critically ill at the time of antimicrobial prescribing.
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literature and findings from previous work exploring the
user’s role in infection control.26 For the inductive
approach, two authors (TMR and LSPM), reviewed the
focus group transcripts independently to allow initial
codes to be generated from differing viewpoints by
line-by-line coding for first order codes.27 28 During
line-by-line coding, the comments provided by the inde-
pendent observers’ were considered with the aim of
complementing areas of reflexivity caused by the ana-
lysts’ own prior experiences.29 After familiarisation with
the transcripts, the researchers independently coded the
data generating a list of emerging categories from the
first order codes and those identified deductively,
addressing the aims of the study design. After meeting
and agreeing on key categories and themes within the
text, the two analysts independently proceeded to sys-
tematically cross-review the text, coding passages based
on these agreed codes and categories, subsequently
grouping them into overarching themes. On review, any
discrepancies were discussed and consensus reached.
Examples of key opinions and ideas from the text for
each main theme identified were then charted to allow
mapping and interpretation of the results.27 Following
synthesis of our findings, 20 new participants were
recruited using the same recruitment agency (Cherry
Picked, UK) in May 2016 to take part in three further
focus group sessions. As a part of these sessions the find-
ings from the initial focus groups were tested for valid-
ation within a new group of citizens (data not shown).
Through this exploratory work it was deemed that satur-
ation of key categories and themes, identified in the ori-
ginal focus group sessions, had been reached; allowing
for progression onto the development and impact of
specific interventions that addressed our findings to be
explored.
Ethics approval
The study protocol was reviewed by the West London
Regional Ethics Committee (REC) and considered to
meet criteria for monitoring under service evaluation
governance structures (REC 15/LO/1269/ICHNT Service
Evaluation SE113).
RESULTS
The median age of participants was 52 (21–69) years
with an equal gender divide. Seven of the participants
were of white ethnicity. Six participants had experience
of infection management as a hospital inpatient (in the
non-critical care setting), with the remaining partici-
pants all having received antimicrobials from other sec-
ondary care pathways across a variety of South-East
England healthcare institutes. These included the
Emergency Department (ED), urgent care centres
(UCC’s) or consultant led outpatient clinics. Two out of
ten participants were identified on screening as poten-
tially having a low health literacy, reporting that they
sometimes, often, or always required help with written
health information on the SILS screening tool.24 This
indicates that our cohort are likely to be more health lit-
erate than the average population, where ∼43% of indi-
vidual citizens would require assistance with written
health information.24 30
Following thematic analysis, 92 subcategories that fell
into 12 categories were derived from the transcripts.
Three interlinking themes were identified (figure 1).
Table 1 summarises key quotes informing the individual
categories and themes referred to within the text
below. The participants described a failure in commu-
nication and information provision from clinicians and
support staff in secondary care, which subsequently
influences the individual’s future ideas about infections
and their management. This alters the individual’s
future actions towards infections and antimicrobials
and can drive non-adherence to prescribed antimicro-
bial regimes and loss to follow-up after discharge from
secondary care.
Failures in communication
Participants described their experiences of being diag-
nosed with an infection in secondary care as one where
they completely lost ownership of their condition.
Control of their illness was taken over by a multitude of
healthcare professionals (HCPs). Recurring instances
were identified where HCP communication with patients
became unilateral when antimicrobial decisions were
being made, with patients being ‘told’ information, often
devoid of key aspects such as names of medications, dura-
tions of treatment and prospective plans about time
courses and potential escalation/de-escalation of therapy.
This led to a significant amount of anxiety and frustration
as the individual searched for answers.
I was told ‘you have an allergy [to penicillin], take this
instead’—Tell me what I am taking and exactly what it is
going to do for me! [65-year-old male]
Moreover, in many cases participants did not feel as if
they were involved in the decision-making process
around their infection management with two-way com-
munication with healthcare professionals perceived as
absent.
Apart from HCP communication with patients, partici-
pants reported becoming frustrated by communication
between HCPs. This is centred primarily on the way in
which information about infections is communicated
from secondary care doctors to primary care doctors on
discharge from the hospital. While patients are provided
with a discharge summary of their stay on leaving the
hospital, it was perceived that this often neglected infor-
mation about their infection and the treatment which
they received while in the hospital. Participants reported
that they were often forced to communicate this infor-
mation directly with their primary care physician on
follow-up visits or were otherwise lost to follow-up after
discharge due to lack of clear communication pathways.
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Failures in information provision
The current volume and quality of information provided
to individuals by HCPs in secondary care causes pro-
blems for patients as it is often poorly explained, with
medical terminology routinely used. This leads to a
feeling of disempowerment with individuals frustrated
that they then have to ‘go away and research it [their
condition] themselves’ (23-year-old female). Fear and
anxiety follows when participants see serious side effects
of treatment ‘like risk of death [and] no one has men-
tioned that to me!’ (30-year-old male). This in turn
causes frustration as participants compare delivery of
information on infections and antimicrobials to that pro-
vided for operations and medications for chronic
disease, such as hypertension. In this example, patients
are provided with explanations of their procedure/con-
dition, their management, and potential complications
which may arise and how these will be dealt with. In con-
trast, information on infection management is seen as a
‘reactive’ process where information is only often pro-
vided once complications have occurred. Furthermore,
patients are often unaware of the timeline for their treat-
ment and the potential complications. This lack of
clarity drives individuals to stop treatments early or
potentially ignore side effects experienced due to false
assumptions and misinformation.
Participants reported that this failure in communica-
tion about infections and antimicrobials drives them to
seek information from a wide range of sources, often with
varying degrees of quality. Participants commonly sought
information independently due to ‘difficulties in acces-
sing [healthcare professionals]’ and the ‘[time] pressures
of work and children’ (65-year-old male). A number of
avenues were preferred such as the Internet, information
leaflets provided with medications and local pharmacies.
Individuals will seek out recommended or official NHS
sources of information which they believe that they can
trust to provide them with information on their infection
or treatment. While these sources are seen as helpful,
patients still prefer to discuss their infection and its man-
agement with a HCP as this provides ‘individualised’
information compared to the ‘standard-reply’ provided
by alternative sources (69-year-old male). This is because
the information provided is seen as being based on the
patient’s own specific situation and issues. Furthermore,
the HCP is a ‘trusted’ source being viewed as an ‘expert’
(69-year-old male).
Influences of future attitudes and behaviours
Participants clearly described how these individual
experiences of poor communication and information
provision influence their future ideas and actions
towards infection management both in secondary care
and in the community. Influences were described from
three sources; personal understanding/experiences,
understanding by proxy and understanding through the
media.
For example, one personal experience was described
by a participant who was told that he had an allergy to
penicillin and told that he would be given a ‘weaker’
type of antibiotic for his infection. When this was per-
ceived not to be effective at clearing up the infection
after 2 days, he stopped taking his medication as:
You know the weaker ones [antibiotics] never seem to
clear the infection up. They are not as strong so they don’t
clear it up. The infection lasts longer [60-year-old male]
This subsequently led to the participant having to
return to secondary care for further treatment of his
Figure 1 The distribution of
themes and categories
contributing to individuals’
experiences of decision making
for infection management in
secondary care pathways.
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Table 1 An analytical framework developing categories and themes for patients’ experiences of infection management in secondary care
Quote Category Theme
“I wasn’t given any education into what to do [with my antibiotics]. The 5thday I felt well and so
thought I would just stop taking the treatment. I was fortunate that my sister explained to me and
made me complete the course” [24-year-old female]
Adherence support Information provision
“Especially I think that you are often given more information when you are taking other
medication… I have allergies to penicillin so always I have to know what kind of antibiotic I have
been given. So unless your issues are more complicated, that’s when they give you more
information, otherwise I feel that they don t provide you with enough” [24-year-old female No. 2]
Comparison with other
treatments
“I like to go and see the doctor… Online can’t see me [sic]. Infection is a thousand different things
and online can’t confidently tell you, this is what you have…” [65-year-old male]“…you are not an
individual to them [corporate pharmacists]. In our case, I think we have the option to be sort of
individuals. That is what I find lovely about our current pharmacy!” [69-year-old male]
Sources Information provision/
communication
“I think what the problem that I have experienced is, is that they will give you a leaflet to read and I
will have to go and research it myself. This is rather than the doctor taking the time to sit down
and talk about how it might affect you, what exactly is in it [the antibiotic]—you know a proper
consultation.” [23-year-old female]“Rather than sitting down and taking the time to explain,
because they use a lot of medical terminology that I do not know what they’re talking about to be
honest. I think that they need to take more time to be honest to sit down and make sure that the
patient knows exactly what they are putting in your body and exactly what all the side effects were.
Because I didn’t know what I was reacting to…” [24-year-old female]
Quality
“I think sometimes the doctors normally come and diagnose you they usually tell…. They don’t
necessarily tell you what they are giving you, they usually prescribe it. Then the nurse just comes
along with a pot full of drugs and you just take them. I think, unless you are intrigued and ask for it
then the nurse will give you that information.” [30-year-old female]
HCP—Patient communication
of information
“When you go into hospital, you feel as though the illness is not yours. You go in to hospital and
everyone takes over, like ‘we do this then we do that later’. You have no ownership in a way. You
are going through it but you have no ownership over what is being done for you or what
medication you are receiving.” [23-year-old female]
Decision-making process Communication
“Tell me yes or tell me no… If you can’t fix it I don’t want to see you again because there will be
no point… We’ve tried this it’s not worked so we tried that… it is endless…” [65-year-old male]
Emotion
“You know, the hospitals I have experienced in [region]—I am not really keen based on the lack of
information. It is more about; we’re doing this operation—get you in, get you out.” [23-year-old
female]
Hospital variability
Continued
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Table 1 Continued
Quote Category Theme
“When I went to A&E I visited my GP … It is more about telling your GP what the symptoms were
and what treatment you had rather than exactly what the infection is” [30-year-old female]“My GP
never knew anything. She had scheduled me in to have the hernia, but the appendix went first.
And she was “oh have you…” [53-year-old male]
HCP—HCP communication of
information
“For me, I do not know the difference between an allergy and side effects. I would normally just try
and cope with it and not go back to the doctors.” [24-year-old female]“I left it a long time and then
I got an infection tracking all the way up [my leg]. I went into A&E as I couldn’t walk. When I was
there they brought some student doctors and said “how bad is this leg” and I thought [this is
bad]!” [60-year-old male]
Personal experience Influence on future attitudes
and behaviours
“They asked whether he was allergic and I said that I do not know he had never had them. After
being given them he really severely reacted. He blew up with vomiting and was very very sick. We
had to go back to casualty and get that sorted. So the thing that worries me about that is that I
remember someone telling me that if you routinely have an operation, you are given penicillin
routinely so it worries me whether that would have an effect if he was ill abroad…” [52-year-old
female]
Proxy experience
“I read an article a while ago about antibiotics and how they made people severely ill. A few
people have died. I think it’s just like… where I have heard about bad experiences…. you know
they have never really pulled through for me.” [21-year-old female]
Media
This data is an extract of quotes derived from thematic analysis of focus group interviews exploring participants’ experiences of infection management in secondary care pathways.
A&E, accident and emergency department; GP, general (primary care) practitioner; HCP, healthcare professional.
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infection due to the poor information provision and
engagement in the decision process surrounding his
infection.
The media’s role in developing the participants’
understanding of infection management arose and was
further explored during the focus group. Participants
reported that the media’s influence occurred through
the portrayal of stories about complications of treatment
and the dangers of AMR. This created fear and mistrust
of medical professionals within our participant group,
and caused participants to be ‘cautious’ when interact-
ing with medical professionals as they are perceived to
‘not say the full story’ (21-year-old female). This distrust
was reported as driving non-adherence to therapy in the
community by several members of the group.
DISCUSSION
Summary of participant impressions
Within our participant group, individuals felt detached,
frustrated and disempowered from involvement in
decision-making about their own infection management
within secondary care. The consequences of the failure
of HCP communication and information provision
reached beyond secondary care, influencing the ideas
and actions towards infections and antimicrobials during
future healthcare interactions along a number of differ-
ent pathways. This fosters feelings of frustration and
anxiety during an individual’s journey through complex
secondary care pathways and potentially drives non-
adherence to prescribed antimicrobial regimes and loss
to follow-up after discharge. These findings highlight
the need for specialists in secondary care to not view
infection management episodes as discrete events, but
as cumulative experiences which have the potential to
drive future non-adherence to prescribed antimicrobial
regimes and thus the promotion of AMR.
Opportunities for educating healthcare providers to
improve patient engagement
Importantly, HCPs must appreciate that engagement in
the decision process for infection management and anti-
microbial prescribing may have an influence on future
patient actions towards infections and antimicrobial use.
These actions can be influenced by personal experience
along with those of friends and family and what is
described in the media. The way in which we communi-
cate information to patients was reported as the most
important aspect in our participants’ experience of
infection management in secondary care and was the
largest influence on future actions in terms of adher-
ence to prescribed antimicrobial regimes and healthcare
seeking behaviours. Participant perception of communi-
cation in secondary care infection-related pathways is of
a unilateral process which does not invite patient partici-
pation. Greater emphasis needs to be placed on educat-
ing HCPs to move away from the decision-maker role31
into a more bilateral structure. Difficulties such as time
pressure on the HCP and the patient is perceived as a
key factor by participants and must be taken into
account when designing interventions to help facilitate
improved communication and patient education during
the decision-making process. The way that these inter-
ventions are designed must be mindful of health literacy,
ensuring that the information provided to patients is
understandable. Within our small cohort, two of the ten
participants met the screening criteria for health illiter-
acy. Within the UK, it is estimated that up to 43% of the
adults cannot understand currently available health
information.24 30 Therefore, along with educating
healthcare providers in how to improve communication
with patients, consideration of the wording and type of
health information supporting this is vital to allow
patient engagement with the decision-making process.
Opportunities for improving patient engagement with
decision-making
Within our cohort, participants felt strongly that the
choice of information provided about their infection
and antimicrobial therapy should be dictated by the
patient’s preference. However, their focus was not pri-
marily on the end decision of whether or not to treat,
but on feeling involved and engaged with the process of
decision-making. This focused on education about their
condition and treatment, communicated effectively to
them. They described a belief that if a trusted clinician
felt they had an infection that required antimicrobial
therapy, then this was appropriate. Whether this is truly
sharing the decision process or not is for consideration,
as SDM classically acknowledges that there is a choice to
be made, with the patient and clinician coming together
to consider available evidence, the patient’s values and
preferences before arriving at a decision.32 However,
Edwards and colleagues suggest that this can still be
classed as sharing the decision (or engaging the patient
in the process) where the focus is placed primarily on
involving the patient in the decision-making process,
rather than on who actually makes the final decision on
management.33 Our participants supported this
approach to engagement by describing how they
become frustrated and distrusting of the recommended
therapy when supporting information about the infec-
tion and the proposed management is perceived to be
withheld from them.
Participants currently view information provided about
infections and antimicrobials as reactive in nature, with
information only provided after a side effect occurs or
the patient fails to respond to a certain type of anti-
microbial, and therapy is escalated. Individuals want pro-
active information to help them understand what they
are receiving, what to expect and what the plan is if the
treatment does not go to plan. This allows them to feel
‘prepared’, ‘confident’ and invested in the healthcare
they are receiving. This is challenging for antimicrobial
prescribing in secondary care, which is often an acute
event, requiring rapid decision-making, and has a short
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duration of therapy.34 Moreover, this highlights a key
area of misunderstanding surrounding infections and
antimicrobial therapy within our participant group that
has been driven by poor communication and informa-
tion provision during previous experiences of infection
management within secondary care. Therefore, future
tools must aim to promote patient engagement with
infection management, considering how they define
engaging patients in the decision process. Moreover,
these interventions must ensure that identified deficien-
cies in how HCP communicate and provide information
to patients are addressed to facilitate improvements in
the current patient experiences.
Strengths and limitations
This qualitative analysis aimed to map the current experi-
ences of patients in antimicrobial decision-making but it
does have limitations. Group facilitation within our study
was carried out by two HCPs, which may have influenced
socially desirable participant responses to certain ques-
tions. To address this dynamic between interviewer and
interviewee, two observers’ comments were also consid-
ered during initial coding to highlight where the inter-
viewer’s position may have directly influenced individual
responses. For example, during discussion of participants’
perceptions of doctors attitude towards prescribing anti-
microbials, one participant apologised after voicing an
opinion about doctors simply wanting to
..sign the prescription and get rid of the patient
[69-year-old male].
The noted anxiety about offending the HCP may have
influenced other participants voicing their true opinion
on the matter. Second, while small, this in-depth study
provides key themes for future studies to explore the
generalisability of and inform the design and evaluation
of appropriate interventions. Furthermore, our findings
were subsequently tested for validation within an inde-
pendent group of citizens to search for further categor-
ies and themes within our local population. Finally, on
comparison of the health literacy of our selected cohort
of participants, the group appeared to be more health
literate than estimates for the general population.
Therefore, during subsequent intervention development
and exploration, this aspect must be highlighted and
considered as this may affect the generalisability of our
results across the population.
CONCLUSION
Within secondary care, specialists are failing to engage
their patients with the decision-making process sur-
rounding infections and their management. This ultim-
ately leads to misinformation, frustration and anxiety
during an individual’s journey through secondary care
pathways and potentially drives non-adherence to pre-
scribed antimicrobial regimes and loss to follow-up in
the community. Clinicians must stop seeing infection
episodes as discrete events and approach them with the
understanding that previous negative experiences drive
subsequent non-adherence to prescribed antimicrobial
regimes and potentially disrupt follow-up of patients
post discharge from secondary care. Poor communica-
tion by HCPs and lack of quality information provided
are the two leading causes for this, often driving indivi-
duals to seek standard information from untrusted
online sources. This aspect must be addressed through
improving HCP education on patient engagement and
through development of interventions to support
patient engagement in the process. Furthermore, these
findings have the potential to translate into other fields
of secondary care, where poor engagement also exists
and benefits in patient outcomes through interventions
promoting improved communication and information
provision are beginning to be reported. We call for the
development of clear and pragmatic mechanisms to
educate HCPs and provide patients with the proactive
information they require about their infection and its
management and engage them with the decision-
making process.
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